VANCOUVER, BC, Dec. 16, 2025 /PRNewswire/ -- Zephyrus Innovations (Zephyrus), a privately-owned medical device company ...
Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...
The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...
Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback